Kumar S, et al. - The objective of this study was to estimate the incidence of (and risk factors for) low bone mass (osteoporosis and/or osteopenia) related fractures in a population-based Barrett's oesophagus (BO) cohort. As compared to the general population, the incidence of osteoporotic fractures was not increased in BO patients. They also noted that the proton pump inhibitors (PPI) use was not related to the increased fracture risk regardless of the duration of therapy or dose.